Pure Global

Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment - Trial NCT06254027

Access comprehensive clinical trial information for NCT06254027 through Pure Global AI's free database. This phase not specified trial is sponsored by Oystershell NV and is currently Not yet recruiting. The study focuses on Onychomycosis. Target enrollment is 132 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06254027
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06254027
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment
Multicentric, Randomized, Evaluator Blinded Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for the Treatment of Onychomycosis

Study Focus

Onychomycosis

Forte

Interventional

device

Sponsor & Location

Oystershell NV

Timeline & Enrollment

N/A

Mar 01, 2024

Sep 01, 2025

132 participants

Primary Outcome

Percentage of healthy surface (Performance)

Summary

The goal of this clinical trial is to evaluate the effectiveness of FORTE, ACTIVE COVER LIGHT
 and Locerylยฎ in the treatment of onychomycosis based on the blinded evaluation of the
 percentage of healthy nail surface compared to baseline.

ICD-10 Classifications

Onychogryphosis
Chromomycosis, unspecified
Onycholysis
Actinomycosis
Blastomycosis

Data Source

ClinicalTrials.gov

NCT06254027

Device Trial